ArticleBMC ophthalmology2018

Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab.

Flora Elwes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.